Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab.
about
Aerosol Immunotherapy with or without Cisplatin for metastatic lung cancer non-small cell lung cancer disease: In vivo Study. A more efficient combination.Is there a room for immune checkpoint inhibitors in early stage non-small cell lung cancer?Efficacy and immune activation of ipilimumab in early-stage lung cancer patients.Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies
P2860
Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Immune Activation in Early-Sta ...... Chemotherapy Plus Ipilimumab.
@en
Immune Activation in Early-Sta ...... Chemotherapy Plus Ipilimumab.
@nl
type
label
Immune Activation in Early-Sta ...... Chemotherapy Plus Ipilimumab.
@en
Immune Activation in Early-Sta ...... Chemotherapy Plus Ipilimumab.
@nl
prefLabel
Immune Activation in Early-Sta ...... Chemotherapy Plus Ipilimumab.
@en
Immune Activation in Early-Sta ...... Chemotherapy Plus Ipilimumab.
@nl
P2093
P2860
P1476
Immune Activation in Early-Sta ...... Chemotherapy Plus Ipilimumab.
@en
P2093
Betty Tong
Chelsae Dumbauld
David Harpole
Debra Shoemaker
Frances McSherry
Frank Dunphy
Jared D Christensen
Jeffrey Clarke
Jeffrey Crawford
P2860
P304
P356
10.1158/1078-0432.CCR-17-2005
P407
P577
2017-09-26T00:00:00Z